Sperogenx Biosciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
- Paid Up Capital ₹ 1.00 M
- Company Age 6 Year, 8 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.00 M
- Revenue Growth 2.59%
- Profit Growth 118.67%
- Ebitda 101.70%
- Net Worth 133.33%
- Total Assets 43.80%
About Sperogenx Biosciences
Sperogenx Biosciences Private Limited (SBPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 23 May 2018 (Six years and eight months 12 days old ). Its registered office is in Bangaluru, Karnataka, India.
The Company is engaged in the Internet Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M.
The company currently has active open charges totaling ₹1.00 M.
Saurabh Garg, Chinnasamy Thiruppathiraja, Arun Surendran, and One other member serve as directors at the Company.
Company Details
-
Location
Bangaluru, Karnataka, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
Social Media
Corporate Identity Details
-
CIN/LLPIN
U73200KA2018PTC124149
-
Company No.
124149
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
23 May 2018
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Bangalore
Industry
Who are the key members and board of directors at Sperogenx Biosciences?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Chinnasamy Thiruppathiraja
|
Managing Director | 14-Jul-2018 | Current |
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
|
Mani Vigneshwaran
|
Additional Director | 10-Apr-2021 | Current |
|
Saurabh Garg
|
Director | 21-Feb-2019 | Current |
|
Arun Surendran
|
Director | 21-Feb-2019 | Current |
Financial Performance of Sperogenx Biosciences.
Sperogenx Biosciences Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 2.59% increase. The company also saw a substantial improvement in profitability, with a 118.67% increase in profit. The company's net worth Soared by an impressive increase of 133.33%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Sperogenx Biosciences?
In 2023, Sperogenx Biosciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Syndicate Diagnostics Private LimitedSaurabh Garg is a mutual person
-
Poct Science House Private LimitedSaurabh Garg is a mutual person
-
Q-Line Biotech Private Limited
Saurabh Garg is a mutual person
-
Heidelco Medicore Private LimitedSaurabh Garg is a mutual person
-
Q-Line Nutraceuticals Private LimitedSaurabh Garg is a mutual person
-
Q-Line Healthcare Private Limited
Saurabh Garg is a mutual person
Charges (Loans)
₹1.00 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 07 Sep 2021 | Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Sperogenx Biosciences?
Unlock and access historical data on people associated with Sperogenx Biosciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Sperogenx Biosciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Sperogenx Biosciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
